Bank of Nova Scotia
BPMC

Bank of Nova Scotia’s Blueprint Medicines BPMC Stock Holding History

Bank of Nova Scotia’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-5,473
Closed -$563K – 1209
2021
Q3 		$563K Buy
+5,473
New +$510K ﹤0.01% 970
2020
Q2 		– Sell
-80,728
Closed -$4.72M – 953
2020
Q1 		$4.72M Sell
80,728
-419
-0.5% -$27K 0.02% 434
2019
Q4 		$6.5M Sell
81,147
-7,746
-9% -$580K 0.02% 472
2019
Q3 		$6.53M Buy
+88,893
New +$7.68M 0.02% 447

Other funds holding BPMC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bank of Nova Scotia's BPMC Position: Q4 2021 in Review

Bank of Nova Scotia sold out of Blueprint Medicines (BPMC) in Q4 2021, closing a stake of 5,473 shares — an estimated $563K sold.

Bank of Nova Scotia first reported a position in BPMC in Q3 2019 and held it in 4 quarters. The position peaked at $6.53M in Q3 2019. 280 funds tracked by Wall St. Rank hold BPMC as of Q4 2021.

  • Bank of Nova Scotia reported no remaining Blueprint Medicines position as of Q4 2021 after selling out during the quarter.
  • Bank of Nova Scotia sold 5,473 Blueprint Medicines shares in Q4 2021, an estimated $563K.
  • Bank of Nova Scotia first reported a position in Blueprint Medicines in Q3 2019 and held it in 4 quarters.
  • Bank of Nova Scotia's Blueprint Medicines position peaked at $6.53M in Q3 2019.
  • 280 funds tracked by Wall St. Rank held Blueprint Medicines as of Q4 2021.

Based on Bank of Nova Scotia's 13F filing for Q4 2021, filed 11 Feb 2022.